Table 4 Antidiabetic medication at the time of hospital discharge in relation to HbA1c-values (obtained ±90 days before hospital admission) for very old patients with type 2 diabetes.
Type of glucose-lowering medication | HbA1c | |||||||
|---|---|---|---|---|---|---|---|---|
<30 | 30–41 | 42–47 | 48–52 | 53–57 | 58–74 | 75+ | Total | |
Acarbose | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 2 (100%) | 0 (0%) | 0 (0%) | 2 (100%) |
Basal Insulin | 1 (0%) | 51 (9%) | 64 (11%) | 75 (13%) | 79 (14%) | 188 (33%) | 105 (19%) | 563 (100%) |
Bolus Insulin | 3 (2%) | 26 (15%) | 23 (14%) | 21 (12%) | 28 (17%) | 44 (26%) | 24 (14%) | 169 (100%) |
DPP-4i | 2 (1%) | 30 (12%) | 56 (22%) | 34 (13%) | 36 (14%) | 56 (22%) | 38 (15%) | 252 (100%) |
GLP-1 RA | 0 (0%) | 5 (16%) | 7 (23%) | 7 (23%) | 1 (3%) | 10 (32%) | 1 (3%) | 31 (100%) |
Metformin | 10 (1%) | 204 (21%) | 254 (26%) | 163 (17%) | 110 (11%) | 169 (17%) | 75 (8%) | 985 (100%) |
SGLT-2i | 0 (0%) | 2 (12%) | 1 (6%) | 2 (12%) | 4 (24%) | 6 (35%) | 2 (12%) | 17 (100%) |
SU | 4 (2%) | 66 (26%) | 53 (21%) | 40 (16%) | 26 (10%) | 48 (19%) | 16 (6%) | 253 (100%) |
Total | 20 (1%) | 384 (17%) | 458 (20%) | 342 (15%) | 286 (13%) | 521 (23%) | 261 (11%) | 2272 (100%) |
